Kavar Capital Partners Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-12	Closed	–	–	281
2015 Q4	$0	Buy	12 +5	+71%	–	﹤0.01%	509
2015 Q3	$0	Sell	7 -1	-13%	–	﹤0.01%	516
2015 Q2	$0	Buy	+8	New	–	﹤0.01%	528